Hypertension 2024 Scientific Sessions  /  03. New Drugs in the Treatment of Hypertension  /  Endothelin Antagonists for Hypertension: Has Their Time Finally Arrived?
Logo

American Heart Association

  64
  0

Final ID:

Endothelin Antagonists for Hypertension: Has Their Time Finally Arrived?

  • Schiffrin, Ernesto  ( SMBD JEWISH GENERAL HOSP , Montreal , Quebec , Canada )
    • Author Disclosures:
    Ernesto Schiffrin: DO have relevant financial relationships ; Consultant:Boehringer Ingelheim:Active (exists now)
Meeting Info:

Hypertension 2024 Scientific Sessions

2024

Chicago, Illinois

Session Info:

03. New Drugs in the Treatment of Hypertension

Thursday, 09/05/2024 , 10:30AM - 12:00PM

Recent Advances Plenary

More abstracts on this topic:
Mechanisms of Endothelin, ETA and ETB Receptors in Hypertension

Pollock David

The Potential Role of Aldosterone Synthase Inhibition to More Effectively Treat Hypertension

Laffin Luke

More abstracts from these authors:
Vγ6+ γδ T cells protect against angiotensin II-induced hypertension and vascular injury in male mice

Paradis Pierre, Tigelaar Robert, Schiffrin Ernesto, Mahmoud Ahmad, Caillon Antoine, Shokoples Brandon, Ferreira Nathanne, Comeau Kevin, Hatano Shinya, Yoshikai Yasunobu, Lewis Julia

You have to be authorized to contact abstract author. Please, Login
Not Available